Viyash Scientific Ltd (VIYASH) — Corporate Action | 1 October 2026
Viyash Scientific completed its acquisition of 100% of BioForLife Italia S.r.l. on October 1, 2026, paying EUR 15.0 million upfront and up to EUR 1.976 million in deferred consideration, finalizing the transaction under the previously disclosed SPA terms.
About Viyash Scientific Ltd (VIYASH)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when VIYASH files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track VIYASH — Free💡 Ask AI about this filing
📊 More VIYASH filings
- Announcement — 28 September 2026Viyash Scientific Limited announced that its trading window will close on October 1, 2026, and remai...
- 🔴 Corporate Action — 18 September 2026Viyash Scientific announced the allotment of 11,07,309 equity shares under its ESOP 2020 and ESOP 20...
- 🔴 Announcement — 8 September 2026Viyash Scientific announced that Italian regulatory approval for its proposed acquisition of BioForL...
- 🔴 Corporate Action — 4 September 2026Viyash Scientific announced the allotment of 612,773 equity shares under its 2020 and 2026 employee ...
- 🔴 Insider Trading — 27 August 2026CA Harbor and CA Hull sold 2.48 million and 2.56 million shares of Viyash Scientific Ltd on August 2...
🔥 Also filed on 1 October 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when VIYASH files new disclosures
Track VIYASH filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VIYASH — FreeFree account · 2 AI queries/day